LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,870,821 | -4.9% | 2,780,261 | 0.0% | 3.33% | +65.9% |
| Q2 2023 | $11,426,873 | +219.9% | 2,780,261 | +56.4% | 2.01% | +171.8% |
| Q1 2023 | $3,572,275 | -36.0% | 1,777,251 | 0.0% | 0.74% | -38.6% |
| Q4 2022 | $5,580,568 | -37.3% | 1,777,251 | 0.0% | 1.20% | -42.1% |
| Q3 2022 | $8,904,000 | -11.3% | 1,777,251 | 0.0% | 2.08% | -22.5% |
| Q2 2022 | $10,041,000 | – | 1,777,251 | – | 2.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|